drugset / Trial / NCT00002466

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

NCT00002466 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug or combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by radiation therapy in treating patients with peripheral neuroectodermal tumors, Ewing's sarcoma, Wilms' tumor, or bone cancer.

Timeline

Start
1990-05
Primary completion
2005-05
Completion
2005-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified 140 mg/kg Intravenous
Subject Cyclophosphamide Other / unclassified 4200 mg/m2 Intravenous
Subject Doxorubicin Other / unclassified 75 mg/m2 Intravenous
Subject Etoposide Small molecule 100 mg/m2 Intravenous
Subject Etoposide Small molecule 500 mg/m2 Intravenous
Subject Etoposide Small molecule 1000 mg/m2 Intravenous
Subject Ifosfamide Small molecule 1800 mg/m2 Intravenous
Subject Ifosfamide Small molecule 9000 mg/m2 Intravenous
Subject Ifosfamide Small molecule 12000 mg/m2 Intravenous
Subject Vincristine Small molecule 2 mg/m2 Intravenous

Indications